Pfizer Inc
NYSE: PFE
▼
33.48
-0.06
-0.18%
1 Day
-
Open
33.47
-
Previous Close
33.54
-
Volume (Avg)
12.02M (20.59M)
-
Day's Range
33.39-33.58
-
52Wk Range
29.83-37.39
-
Market Cap.
199.80B
-
Dividend Rate (Yield)
1.28 (3.82%)
-
Beta
1.02
-
Shares Outstanding
5.97B
-
P/E Ratio (EPS)
28.17 (1.19)
Top Stories
-
Millennials already have their apps — now VCs want tech for people over 50
CNBC 56 mins ago -
Today's Research Reports on Stocks to Watch: Abbott Laboratories and Pfizer Inc.
NASDAQ -
Lightning Round: Jim Cramer Shares His Thoughts On GameStop, Pfizer And More
Benzinga -
Analyst Prescribes Neutral Rating For Pfizer Shares
Benzinga -
Pfizer CEO: The Future Of American Innovation Rests On A Competitive U.S. Tax Policy
Forbes 1 day ago -
Pfizer Downgraded on Patent Expiration for Viagra: Credit Suisse
Investopedia -
Tesla Started At Neutral, High Risk; Amazon Gets Price Target Hike
Investors Business Daily -
Merck (MRK) and Pfizer (PFE) Collaborate with Corning (GLW) to Modernize Pharmaceutical Glass Packaging
StreetInsider -
Pfizer shares downgraded because Viagra patent is expiring later this year
CNBC -
Pfizer nabs European rights to antifungal isavuconazole
Seeking Alpha -
Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging
NASDAQ -
Trump brings companies to White House for another jobs announcement
CNN Money -
Pfizer Fueling Growth Of Competitors' Pipelines
Forbes -
Corning, with assists from Pfizer and Merck, plans $500M pharma glass project that Trump announced
FiercePharma -
BP Adams Bowing to 'Anti-Semitic Bullying' in Opposing Development: Builder
DNAinfo New York 3 hrs ago -
Eric Adams's Support Of Pfizer Site Development Contingent On More Affordable Housing
Gothamist -
Pfizer Inc. (PFE) Closes 0.18% Down on the Day for July 21
Equities -
Williamsburg's Pfizer-replacing megaproject needs more affordable housing, says borough president
Curbed
